Daniel E. Kremens, MD, JD, FAAN

Co-Director, Movement Disorders Program, Vice Chair of Education in Dept of Neurology
Department of Neurology, Sidney Kimmel Medical College at Jefferson University

Poster(s):

• (87) Efficacy and safety of tavapadon, an orally administered, once-daily, selective D1/D5 dopamine agonist, adjunctive to levodopa for treatment of Parkinson’s disease with motor fluctuations
  Wednesday, October 29, 2025